Search





Search





News

All

Editors' Picks

Stocks

Indices

Market Movers

Commodities

Cryptocurrencies

Forex

Presentations

Earnings

Transcripts

Technical Analysis

Economic Indicator

Other

Presentations

Diodes Q3 2026 Revenue Hits Record, Q4 Growth Expected

Diodes reported record Q3 2026 revenue of $532.6 million, a 36.2% non-GAAP gross margin and $1.18 in adjusted EPS, with further growth projected for Q4.

TradingKey

Fri, Nov 6

Presentations

Compass Q3 Revenue Reaches $3.9 Billion After Anywhere Acquisition

Compass reported Q3 2026 revenue of $3.90 billion, adjusted EBITDA of $306 million and $240 million in free cash flow after acquiring Anywhere.

TradingKey

Fri, Nov 6

Presentations

Conduent Q3 Revenue Falls 11.7% as Margin Expands

Conduent’s Q3 2026 revenue fell 11.7%, while adjusted EBITDA and margin increased as cost savings offset contract losses and lower volumes.

TradingKey

Fri, Nov 6

Presentations

Callaway Golf Raises 2026 Outlook as Q3 Margins Expand

Callaway Golf raised its 2026 sales and adjusted EBITDA outlook after Q3 margins expanded and adjusted EBITDA rose despite lower quarterly revenue.

iShares Short-Term California Muni Active ETF

TradingKey

Fri, Nov 6

Presentations

BlackLine Q3 Revenue Rises 8% as Operating Margin Reaches 26%

BlackLine Q3 2026 revenue rose 8% to $193.4 million, ARR reached $735 million, and its non-GAAP operating margin increased to 25.9%.

TradingKey

Fri, Nov 6

Presentations

BILL Q1 Revenue Rises 13% as Core Growth Drives GAAP Profit

BILL’s fiscal Q1 2027 revenue rose 13% to $353.8 million as core revenue and payment activity grew, while the company moved to GAAP operating profit.

BILL Holdings Inc

TradingKey

Fri, Nov 6

Earnings

Utz Q3 2026 Earnings: Inflation Compresses Margins

Utz Brands’ fiscal Q3 2026 revenue fell 2.3% to $369.2 million, while adjusted EPS declined to $0.10 from $0.23. Adjusted gross margin contracted 530 basis points to 27.2% as supply-chain inflation, channel mix, and lower volumes outweighed pricing and lower adjusted SG&A. Branded Salty Snacks organic sales rose 0.3%, but Non-Branded & Non-Salty Snacks fell 23.8%. The company used $4.9 million of operating cash and did not update 2026 guidance because its pending take-private transaction is expected to close in the fourth quarter.

TradingKey

Fri, Nov 6

Presentations

Arteris Q3 Revenue Jumps 48%, Full-Year Outlook Increased

Arteris reported 48% third-quarter revenue growth, record ACV plus royalties and backlog, and increased its full-year 2026 revenue outlook.

TradingKey

Fri, Nov 6

Presentations

NGL Energy Raises FY2027 EBITDA Guidance on Record Water Volumes

NGL Energy Partners raised fiscal 2027 Adjusted EBITDA guidance to $735 million-$745 million as record water volumes supported 15% quarterly growth.

TradingKey

Fri, Nov 6

Presentations

Karman Raises FY2026 Outlook as Q3 Revenue Jumps 66%

Karman raised its fiscal 2026 revenue and adjusted EBITDA guidance after Q3 revenue rose 66% and backlog more than doubled to $1.67 billion.

Karman Holdings Ord Shs

TradingKey

Fri, Nov 6

Presentations

iRhythm Raises 2026 Outlook as Q3 Revenue Rises 14.9%

iRhythm raised its 2026 revenue and adjusted EBITDA margin guidance after Q3 revenue rose 14.9%, while litigation charges widened its GAAP net loss.

iRhythm Technologies Inc

TradingKey

Fri, Nov 6

Stocks

From Global Growth to Cultural Connection: OMODA & JAECOO Resonates with a New Generation

WUHU, China, Nov. 6, 2026 /PRNewswire/ -- In just three and a half years,OMODA & JAECOO has surpassed 1.4 million cumulative global sales, doubling year after year for three consecutive years. In September 2026, global sales reached 73,421 vehicles, up 123% year-on-year. What stands out beyond p...

PR Newswire

Fri, Nov 6

Presentations

ibex Raises FY2027 Outlook After Q1 Revenue Grows 16%

ibex raised its fiscal 2027 revenue and adjusted EBITDA outlook after Q1 revenue grew 16% and adjusted EBITDA increased 29% on stronger margins.

TradingKey

Fri, Nov 6

Presentations

Halozyme Raises 2026 Outlook as Q3 Revenue Jumps 39%

Halozyme raised its 2026 guidance after Q3 revenue increased 39% to a record $493 million, driven by 44% growth in ENHANZE royalty revenue.

Halozyme Therapeutics Inc

TradingKey

Fri, Nov 6

Presentations

Funko Q3 Sales Rise 3% as Margins Expand; 2026 Outlook Maintained

Funko’s Q3 2026 sales rose 3% to $258.3 million as core collectibles and Europe offset a Loungefly decline, while margins expanded and full-year guidance was maintained.

TradingKey

Fri, Nov 6

Presentations

Blend Labs Q3 Revenue Edges Higher as Q4 Decline Is Expected

Blend Labs posted 1% Q3 2026 revenue growth and a 14% increase in non-GAAP operating income, while forecasting a fourth-quarter revenue decline.

TradingKey

Fri, Nov 6

Presentations

Blink Charging Posts First Positive Adjusted EBITDA, Cuts 2026 Revenue Outlook

Blink Charging posted its first positive quarterly adjusted EBITDA in Q3 2026 as non-GAAP margins improved, while revenue fell 32% and its full-year outlook was reduced.

Blink Charging Co

TradingKey

Fri, Nov 6

Presentations

AvePoint Q3 ARR Rises 27% as Operating Margin Narrows

AvePoint’s Q3 2026 revenue rose 19% and ARR increased 27%, while non-GAAP operating margin narrowed and full-year guidance moved modestly higher.

TradingKey

Fri, Nov 6

Presentations

A10 Networks Raises 2026 Outlook as Q3 Revenue Hits Record

A10 Networks raised its 2026 revenue and non-GAAP EPS growth outlook after Q3 revenue rose 23% to a record $91.5 million and profitability strengthened.

A10 Networks Inc

TradingKey

Fri, Nov 6

Earnings

Elanco Q3 2026 Earnings: Pet Health Growth Expands Margins

Elanco Animal Health reported Q3 2026 revenue of $1.265 billion, up 11% year over year and 9% on an organic constant-currency basis. Adjusted EPS rose 42% to $0.27, while adjusted EBITDA increased 23% to $243 million and adjusted gross margin expanded 300 basis points to 56.1%. Pet Health led growth, supported by Zenrelia and Credelio Quattro, while poultry revenue declined. Elanco raised its full-year revenue, adjusted EBITDA, and adjusted EPS guidance and ended the quarter with a 2.9x net leverage ratio.

Elanco Animal Health Inc

TradingKey

Fri, Nov 6

1...83 84 85

85/500

86 87...500 

Featured Tools

marketing_marketsTitle

calendar_economicCalendar

Economic Calendar

search.intelligent.strategy

article_asider_weekly_report

Popular Instruments

link

Name

Price

Chg%

link

US October PPI Preview: Fed Rate Hike Expectations Rise, PPI May Be Key Variable; How Will US Stocks, Dollar, and Gold Move?

DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video

Gold Price Forecast: Gold Tumbles Below $3,900 as Trump Says No Need for Iran Deal; Can October PPI Spur a Rebound?

Cisco Stock Retests $101.60 Ahead of Q1 Results, With AI Orders in Focus

【US Pre-Market】Nvidia Rebounds Over 2%; Microsoft Falls Over 2% Amid Massive Global Outage; October PPI Due

link

Dell Technologies Inc Stock (DELL) Opened Down by 3.57% on Nov 13: Facts Behind the Movement

17 minutes ago

Advanced Micro Devices Inc Stock (AMD) Opened Down by 5.37% on Nov 13: Facts Behind the Movement

17 minutes ago

Cisco Systems Inc Stock (CSCO) Opened Down by 3.81% on Nov 13: Key Drivers Unveiled

17 minutes ago

Broadcom Inc Stock (AVGO) Opened Down by 4.37% on Nov 13: A Full Analysis

17 minutes ago

Arm Holdings PLC Stock (ARM) Opened Down by 3.25% on Nov 13: Drivers Behind the Movement

17 minutes ago